Welcome to GTx, Inc., a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other serious medical conditions.

Our recognized scientific expertise is in the discovery and development of novel, selective small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. Click to learn more about our products in development. More...

GTx, Inc. To Host Second Quarter 2015 Financial Results Conference Call and Webcast Read More...

GTx Appoints Diane Young, M.D. as Vice President, Chief Medical Officer Read More...

GTx Regains Compliance with NASDAQ Bid Price Requirement Read More...